Carcinoma Clinical Trials

Active, Not Recruiting

Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations

NCT03047213

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +18 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

Keck Medical Center of USC Pasadena Pasadena, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View all 20 locations

View Trial Details

Active, Not Recruiting

Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors

NCT04079712

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +20 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

University of Arizona Cancer Center-North Campus Tucson, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View all 46 locations

View Trial Details

Active, Not Recruiting

Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2

NCT03284385

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

UCSF Medical Center-Mount Zion San Francisco, California, United States

UCSF Medical Center-Mission Bay San Francisco, California, United States

View all 29 locations

View Trial Details

Active, Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02465060

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Thomas Hospital Fairhope, Alabama, United States

Mobile Infirmary Medical Center Mobile, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

View all 1411 locations

View Trial Details

Active, Not Recruiting

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

NCT05564403

Conditions: Adenocarcinoma, Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma, +28 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States

View all 208 locations

View Trial Details

Active, Not Recruiting

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

NCT04068194

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +24 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

View all 46 locations

View Trial Details

Active, Not Recruiting

An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

NCT05876754

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: Erebouni MC Yerevan, Armenia

National Center of Oncology of Ra M Yerevan, Armenia

Royal brisbane & Women's Hospital Brisbane, Australia

St Vincent's Hospital Fitzroy, Australia

View all 84 locations

View Trial Details

Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

NCT04460937

Conditions: Adenocarcinoma Of Esophagus, Brain Diseases, Brain Neoplasms, +80 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Northwestern University Chicago, Illinois, United States

University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

NCT05316155

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: University of Alabama at Birmingham - The Kirklin Clinic Birmingham, Alabama, United States

University of Southern California Los Angeles, California, United States

Urology Associates of Denver Lone Tree, Colorado, United States

Urological Research Network Hialeah, Florida, United States

View all 59 locations

View Trial Details

Active, Not Recruiting

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

NCT02954874

Conditions: Breast Carcinoma In Situ, Breast Carcinoma in Situ, Breast Diseases, +15 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Southern Cancer Center PC-Daphne Daphne, Alabama, United States

Southern Cancer Center PC-Mobile Mobile, Alabama, United States

Southern Cancer Center PC-Providence Mobile, Alabama, United States

View all 919 locations

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions